Enhancing X-ray Activated Photodynamic Therapy with Supported Lipid Bilayer-Coated Radioluminescent Nanoparticles

We report the synthesis of supported lipid bilayer (SLB)-coated radioluminescent nanoparticles (RLNPs) possessing a lanthanide-based core for low-dose X-ray activated photodynamic therapy (XPDT). Methylene blue (MB) photosensitizer molecules, incorporated within the SLB, are excited by energy transfer from europium, leading to an enhanced generation of reactive oxygen species by the XPDT effect. The stability and biophysical features of the bilayer coating were studied using Langmuir monolayers, as well as dynamic light scattering and zeta potential. MB loading within lipid bilayers was confirmed by pressure-area monolayer isotherms and quantified by fluorescence spectroscopy. In vitro XPDT studies were carried out on A549 lung cancer cells to characterize NP localization and cell damage. Notably, radiation enhancement ratios up to 4.6 were observed using a low radiation dose of 2 Gy and 200 μg mL<sup>-1</sup> SLB-MB-RLNPs illustrating their potential in low-dose XPDT.

Authors

Institutions

Publication Details

Journal
Langmuir
Published
2025-10-08
DOI
https://doi.org/10.1021/acs.langmuir.5c03152
Primary Topic
Nanoplatforms for cancer theranostics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Enhancing X-ray Activated Photodynamic Therapy with Supported Lipid Bilayer-Coated Radioluminescent Nanoparticles

Christine DeWolf, Pedro Mena‐Giraldo, Gabrielle A. Mandl, Nicolas Bondon et al.
Langmuir
Nanoplatforms for cancer theranostics
article

Enhancing X-ray Activated Photodynamic Therapy with Supported Lipid Bilayer-Coated Radioluminescent Nanoparticles

Christine DeWolf, Pedro Mena‐Giraldo, Gabrielle A. Mandl, Nicolas Bondon, John A. Capobianco, Zoey Ferron, Niusha Sadeghipour
article en

Abstract

We report the synthesis of supported lipid bilayer (SLB)-coated radioluminescent nanoparticles (RLNPs) possessing a lanthanide-based core for low-dose X-ray activated photodynamic therapy (XPDT). Methylene blue (MB) photosensitizer molecules, incorporated within the SLB, are excited by energy transfer from europium, leading to an enhanced generation of reactive oxygen species by the XPDT effect. The stability and biophysical features of the bilayer coating were studied using Langmuir monolayers, as well as dynamic light scattering and zeta potential. MB loading within lipid bilayers was confirmed by pressure-area monolayer isotherms and quantified by fluorescence spectroscopy. In vitro XPDT studies were carried out on A549 lung cancer cells to characterize NP localization and cell damage. Notably, radiation enhancement ratios up to 4.6 were observed using a low radiation dose of 2 Gy and 200 μg mL<sup>-1</sup> SLB-MB-RLNPs illustrating their potential in low-dose XPDT.

LangmuirVol. 41(41)
Center for NanoScience (DE), Laboratoire de Mathématiques d'Orsay (FR), Centre de Nanosciences et de Nanotechnologies (FR), Pharmac (NZ), Concordia University (CA), Université de Montréal (CA)
Openalex Percentile: Top 73%
Nanoplatforms for cancer theranostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.